Mizuho reiterates Southwest Gas stock rating on regulatory progress

Southwest Gas reported Q3 2026 adjusted EPS of $0.20, above Mizuho’s $0.12 estimate and the Street estimate of $0.14 cited in the main report; a separate recent-news passage gives a $0.18 consensus and reports revenue of $298.18 million versus $346.96 million expected. Mizuho reiterated its Outperform rating and $103 price target, while noting regulatory uncertainty after Arizona Corporation Commission election results. Arizona rate-case hearings are expected to begin in December, with rates targeted for April 2027; management is expected to provide refreshed long-term guidance, including the full $2.3 billion Great Basin expansion, on the Q4 call.

Analysis

The earnings beat is a weak signal of underlying demand: in a seasonally light quarter, reported EPS can move on rate timing and financing costs without establishing a durable improvement in customer economics. The revenue shortfall therefore matters less than whether allowed returns and customer growth translate into operating cash flow after capex; verify cash flow, financing costs, and the revenue/cost pass-through mix on the call.

The more consequential catalyst is regulatory. Arizona’s December hearings create a near-term sentiment and valuation risk, while the targeted April 2027 rates and the forthcoming guidance update determine whether planned investment converts into recoverable rate base. Political uncertainty can raise the perceived cost of capital before it changes an actual commission decision. The $2.3 billion Great Basin expansion may support longer-term growth, but also raises execution, funding, and recovery-timing questions; do not capitalize management’s growth framing until funding and regulatory treatment are clearer.

Near term, with shares reported near their 52-week high, the asymmetric risk is that a routine EPS beat is already reflected while Arizona uncertainty and the next guidance update remain unresolved. Over 6–18 months, successful rate recovery could support earnings, but delayed recovery or higher financing costs would weaken that case. The thesis is falsified positively by guidance that quantifies timely recovery and funding, and negatively by adverse Arizona decisions, capex slippage, or deterioration in cash flow/debt metrics.

Key Decisions for Investors

• Avoid chasing SWX on the headline beat; consider an underweight versus a diversified regulated-utility basket until the Arizona hearing path and updated guidance clarify the risk/reward.
• Use the fourth-quarter 2026 call as the next decision point: verify Great Basin’s financing plan, expected rate-base contribution, recovery timing, and cash-flow implications rather than relying on EPS alone.
• Track the December Arizona hearings and subsequent commission signals. Reassess the underweight if the process supports timely recovery; reduce exposure further if decisions imply materially delayed or weaker returns.
• Do not treat the reported revenue miss as decisive without understanding utility pass-through accounting. Escalate only if it coincides with weaker customer growth, operating cash flow, or guidance.